These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8937249)

  • 61. Gamma interferon in the treatment of Kala-azar and other forms of Leishmaniasis.
    Sundar S; Murray HW
    J Assoc Physicians India; 1995 May; 43(5):348-50. PubMed ID: 9081967
    [No Abstract]   [Full Text] [Related]  

  • 62. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.
    Rihl M; Stoll M; Ulbricht K; Bange FC; Schmidt RE
    J Infect; 2006 Jul; 53(1):e25-7. PubMed ID: 16274744
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Problems in the treatment of kala-azar: case report.
    Nyakundi PM; Rashid JR; Wasunna KM; Were JB; Muigai R; Kirigi G; Mbugua J
    East Afr Med J; 1995 Jun; 72(6):406-8. PubMed ID: 7498017
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Miltefosine--the long-awaited therapy for visceral leishmaniasis?
    Herwaldt BL
    N Engl J Med; 1999 Dec; 341(24):1840-2. PubMed ID: 10588972
    [No Abstract]   [Full Text] [Related]  

  • 65. An oral drug for leishmaniasis.
    Jacobs S
    N Engl J Med; 2002 Nov; 347(22):1737-8. PubMed ID: 12456848
    [No Abstract]   [Full Text] [Related]  

  • 66. Recent strategies for the development of oral medicines for the treatment of visceral leishmaniasis.
    de Souza ML; Gonzaga da Costa LA; Silva EO; de Sousa ALMD; Dos Santos WM; Rolim Neto PJ
    Drug Dev Res; 2020 Nov; 81(7):803-814. PubMed ID: 32394440
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acivicin: a highly active potential chemotherapeutic agent against visceral leishmaniasis.
    Mukherjee T; Roy K; Bhaduri A
    Biochem Biophys Res Commun; 1990 Jul; 170(2):426-32. PubMed ID: 2383250
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ketoconazole in visceral leishmaniasis.
    Sundar S; Kumar K; Singh VP
    Lancet; 1990 Dec 22-29; 336(8730):1582-3. PubMed ID: 1979393
    [No Abstract]   [Full Text] [Related]  

  • 69. Compassionate use of sitamaquine in an HIV-positive patient with visceral leishmaniasis.
    Rashid JR; Nyakundi PM; Kirigi G; Kinoti D; Wasunna MK
    Trans R Soc Trop Med Hyg; 2002; 96(5):533-4. PubMed ID: 12474482
    [No Abstract]   [Full Text] [Related]  

  • 70. Ketoconazole in treatment of visceral leishmaniasis.
    Wali JP; Aggarwal P; Gupta U; Saluja S; Singh S
    Lancet; 1990 Sep; 336(8718):810-1. PubMed ID: 1976166
    [No Abstract]   [Full Text] [Related]  

  • 71. Visceral leishmaniasis: biology of the parasite.
    Hommel M
    J Infect; 1999 Sep; 39(2):101-11. PubMed ID: 10609526
    [No Abstract]   [Full Text] [Related]  

  • 72. Clinical and experimental advances in treatment of visceral leishmaniasis.
    Murray HW
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2185-97. PubMed ID: 11451673
    [No Abstract]   [Full Text] [Related]  

  • 73. Leishmaniasis.
    Kern P
    Antibiot Chemother (1971); 1981; 30():203-23. PubMed ID: 7259132
    [No Abstract]   [Full Text] [Related]  

  • 74. The use of itraconazole in the treatment of leishmaniasis caused by Leishmania aethiopica.
    Akuffo H; Dietz M; Teklemariam S; Tadesse T; Amare G; Berhan TY
    Trans R Soc Trop Med Hyg; 1990; 84(4):532-4. PubMed ID: 1965355
    [No Abstract]   [Full Text] [Related]  

  • 75. Leishmaniasis: some recent developments in chemotherapy.
    Cook GC
    J Antimicrob Chemother; 1993 Mar; 31(3):327-30. PubMed ID: 8486567
    [No Abstract]   [Full Text] [Related]  

  • 76. Tuberculin sensitivity in kala-azar.
    Rees PH; Kager PA; Muriithi MR; Wambua PP; Shah SD; Butterworth AE
    Trans R Soc Trop Med Hyg; 1981; 75(5):630-1. PubMed ID: 7330918
    [No Abstract]   [Full Text] [Related]  

  • 77. Antituberculous drugs and kala-azar.
    Lancet; 1981 Aug; 2(8241):304. PubMed ID: 6114342
    [No Abstract]   [Full Text] [Related]  

  • 78. Kala-azar: current status of experimental chemotherapy.
    Katiyar JC; Anuradha ; Sharma S
    Med Res Rev; 1992 Sep; 12(5):473-504. PubMed ID: 1513185
    [No Abstract]   [Full Text] [Related]  

  • 79. Blood transfusion in the care of patients with visceral leishmaniasis: a review of practices in therapeutic efficacy studies.
    Dahal P; Singh-Phulgenda S; Wilson J; Cota G; Ritmeijer K; Musa A; Alves F; Stepniewska K; Guerin PJ
    Trans R Soc Trop Med Hyg; 2024 Aug; 118(8):481-490. PubMed ID: 38690667
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Response to ketoconazole in two cases of longstanding cutaneous leishmaniasis.
    Viallet J; MacLean JD; Robson H
    Am J Trop Med Hyg; 1986 May; 35(3):491-5. PubMed ID: 3706620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.